SCHEMBL25855133

SCHEMBL25855133

c1ccc(-c2cc(-c3ccccc3)nc(-c3cc(-c4ccc(-c5ccccc5)c5ccccc45)cc4c3oc3cc5ccccc5cc34)n2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACACA Q13085 2/20 0.36
▸ KMT2A Q03164 6/20 0.35
▸ MAPK1 P28482 3/20 0.35
▸ HSD17B10 Q99714 3/20 0.34
▸ TSHR P16473 2/20 0.34
▸ CYP1A1 P04798 1/20 0.34
▸ CYP1B1 Q16678 1/20 0.34
▸ ALDH1A1 P00352 7/20 0.34
▸ HPGD P15428 6/20 0.34
▸ MAPT P10636 5/20 0.34
▸ KDM4E B2RXH2 5/20 0.34
▸ MEN1 O00255 5/20 0.33
▸ L3MBTL1 Q9Y468 2/20 0.33
▸ ADORA2A P29274 1/20 0.33
▸ ADORA1 P30542 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ NTSR1 P30989 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26420659 0.91 KMT2A (0.35) ACACAKMT2AMAPK1HSD17B10CYP1A1
SCHEMBL24586403 0.91 MAPT (0.36) KMT2AMAPK1HSD17B10TSHRALDH1A1
SCHEMBL24066223 0.90 ENPP1 (0.40) ACACAKMT2AMAPK1HSD17B10TSHR
SCHEMBL26416161 0.86 MEN1 (0.40) ACACAKMT2AMAPK1HSD17B10CYP1A1
SCHEMBL23597640 0.86 — —
SCHEMBL25666485 0.86 ENPP1 (0.41) ACACAKMT2AMAPK1HSD17B10TSHR
SCHEMBL26416179 0.85 CYP1A1 (0.44) KMT2AMAPK1HSD17B10TSHRCYP1A1
SCHEMBL24066229 0.85 MEN1 (0.42) ACACAKMT2AMAPK1HSD17B10TSHR
SCHEMBL25666491 0.85 MEN1 (0.42) ACACAKMT2AMAPK1HSD17B10TSHR
SCHEMBL24066091 0.85 ENPP3 (0.40) ACACAKMT2AMAPK1HSD17B10TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230320211-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-10-05 — — US disclosed
US-20230320211-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-10-05 — — US disclosed
EP-4206198-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT Materials Co., Ltd. (KR) 2023-07-05 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230320211-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE ORC3, CRY1, SUN2 ACACA 1847/4885KMT2A 1149/4885MAPK1 3914/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback